Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

293
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
293
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

228
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
228
Positron Emission Tomography01:29

Positron Emission Tomography

6.4K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current Status and Developments in Biodosimetry Research in India.

Journal of medical physics·2026
Same author

Assessing the radiation-induced bystander effect in radionuclide therapy using targeted radiopharmaceuticals.

EJNMMI radiopharmacy and chemistry·2025
Same author

Synthesis and Evaluation of [<sup>177</sup>Lu]Lu-Labeled-NLS-Trastuzumab Conjugate for Targeting of HER2 Positive Metastatic Breast Cancer: Evaluating the Effect on Intracellular Localization.

ACS medicinal chemistry letters·2025
Same author

Superior affinity of ubiquicidin peptide united with <i>ortho</i>-borylated acetophenone to an amine-containing model bacterial membrane.

Soft matter·2025
Same author

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

EJNMMI radiopharmacy and chemistry·2025
Same author

Epigenetic targeting of MECOM/KRAS axis by JIB-04 impairs tumorigenesis and cisplatin resistance in MECOM-amplified ovarian cancer.

Cell death discovery·2025

Related Experiment Video

Updated: Nov 4, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.2K

Combination radionuclide therapy: A new paradigm.

Shishu Kant Suman1, Suresh Subramanian1, Archana Mukherjee1

  • 1Radiopharmaceuticals Division, Bhabha Atomic Research Centre; Homi Bhabha National Institute, Mumbai 400094, India.

Nuclear Medicine and Biology
|May 24, 2021
PubMed
Summary
This summary is machine-generated.

Combination radionuclide therapy (CRT) combines targeted molecular radionuclide therapy (MRT) with other treatments to overcome cancer resistance. Tailoring CRT to individual patients is key for effective cancer management.

Keywords:
Combination radionuclide therapyMolecular radionuclide therapyPeptide receptor radionuclide therapyRadioimmunotherapyTherapeutic radiopharmaceuticals

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.3K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.7K

Related Experiment Videos

Last Updated: Nov 4, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.2K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.3K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.7K

Area of Science:

  • Oncology
  • Radiotherapy
  • Nanomedicine

Background:

  • Targeted molecular radionuclide therapy (MRT) shows promise for various cancers.
  • Cancer treatment often involves combination strategies to overcome resistance.
  • Combination radionuclide therapy (CRT) integrates MRT with other modalities.

Purpose of the Study:

  • To explore the potential of combination radionuclide therapy (CRT) in cancer treatment.
  • To review strategies for enhancing therapeutic efficacy by combining MRT with other treatments.
  • To highlight the role of nanotechnology in advancing CRT.

Main Methods:

  • Review of existing literature on combination radionuclide therapy.
  • Analysis of synergistic effects between MRT, chemotherapy, and radiotherapy.
  • Exploration of radiosensitizers and nanotechnology in CRT.

Main Results:

  • Combination therapies, including CRT, show encouraging results in preclinical and clinical studies.
  • Combining MRT with chemotherapy or beam radiation enhances anti-tumor response.
  • Nanotechnology offers platforms for precise and personalized CRT.

Conclusions:

  • CRT is a promising approach for cancer management, offering enhanced therapeutic index.
  • Successful CRT relies on understanding radiobiological principles and patient-specific profiles.
  • Personalized CRT strategies are crucial for future cancer treatment.